Staining for USP39 was increased in glioma samples (Fig. 1a), and levels in high-grade gliomas (WHO III–IV; n = 28) were increased compared with low-grade gliomas (WHO II; n = 18) and nonneoplastic human brain tissue samples (n = 6, Fig. 1b). The gene discussed is USP39; the disease is central nervous system cancer.